Fifty Shades of GATA2 Mutation: A Case of Plasmablastic Lymphoma, Nontuberculous Mycobacterial Infection, and Myelodysplastic Syndrome

Clin Lymphoma Myeloma Leuk. 2019 Sep;19(9):e532-e535. doi: 10.1016/j.clml.2019.05.015. Epub 2019 May 29.

Authors

Bita Fakhri¹, Amanda F Cashen¹, Eric J Duncavage², Marcus P Watkins¹, Lukas D Wartman¹, Nancy L Bartlett³

Affiliations

¹ Division of Oncology, Siteman Cancer Center, Washington University School of Medicine, St Louis, MO.
² Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO.
³ Division of Oncology, Siteman Cancer Center, Washington University School of Medicine, St Louis, MO. Electronic address: nbartlet@wustl.edu.

PMID: 31279773
DOI: 10.1016/j.clml.2019.05.015

No abstract available

Keywords: Allogeneic stem cell transplant; EBV-associated lymphoma.

Publication types

Case Reports

MeSH terms

Biomarkers
Biopsy
Bone Marrow / pathology
Combined Modality Therapy
DNA Mutational Analysis
Epstein-Barr Virus Infections / complications
Epstein-Barr Virus Infections / virology
GATA2 Transcription Factor / genetics*
Herpesvirus 4, Human
Humans
Immunohistochemistry
Immunophenotyping
Male
Mutation*
Mycobacterium Infections, Nontuberculous / diagnosis*
Mycobacterium Infections, Nontuberculous / etiology
Mycobacterium Infections, Nontuberculous / therapy
Myelodysplastic Syndromes / diagnosis*
Myelodysplastic Syndromes / etiology
Myelodysplastic Syndromes / therapy
Plasmablastic Lymphoma / diagnosis*
Plasmablastic Lymphoma / etiology
Plasmablastic Lymphoma / therapy
Treatment Outcome
Young Adult

Substances

Biomarkers
GATA2 Transcription Factor
GATA2 protein, human